Search by Products Line : Gastroenterology LineFound 8 Product(s)
DECAPRENO is Cholecalciferol / Vitamin D3 for vitamin D Deficiency patients
Each Ampoule : 1 ml contains 200 000 IU/ ml Cholecalciferol
For Oral or I.M Injection use
Deetrio tablets contain vitamin D3 cholecalciferol 5000 IU and calcium carbonate 228 mg.
For treatment and prophylaxis of vitamin D deficiency and insufficiency.
The Effective Worldwide, Branded Metronidazole against both
Protozoal and Anaerobic Infections.
Nausilex is a potent anti-Nausea and anti-Emetic, it is highly selective in blocking D2 receptors found in the CTZ thus raising the sensitivity threshold of the vomiting center in the brain stem.
Reiferon Retard is the 3rd Worldwide Novel Pegylated Hansenula-derived Recombinant Interferon alfa-2a for subcutaneous administration.
In its dedication to the Viral Hepatitis Dilemma, MINAPHARM introduced Ribavirin® which is a nucleoside analogue with anti-viral activity against a number of DNA and RNA viruses.
MINAPHARM- Egypt(under license of Dr. Falk- Germany) was honored since the beginning of this millennium to introduce to the Egyptian Pharmaceutical Market the branded Mesalazine, Salofalk®; The Active Principle where it is required.
MINAPHARM- Egypt(under license of Dr. Falk- Germany) was honored since the mid nineties to introduce to the Egyptian Pharmaceutical Market the First branded UDCA (Ursodeoxycholic acid) ever, Ursofalk®; The True Therapeutic Bile Acid & The Decades of Clinical Efficacy in the Hepatology Field.
As a global leader in biotechnology & cellular engineering, ProBioGen-Minapharm
As a continuation of Minapharm unique series of "Expert Panel",
The meeting was chaired by Prof. Abdel-Shakour EL MOHAMADY.
The First Netilmicin The Least Resistance
The First Netilmicin Combination the Quick Relief for Ocular Inflammation
Striking Glaucoma Treatment Goals Balancing EFFICACY, COMPLIANCE & AFFORADABILITY
Robust & long lasting correction of serum vitamin D levels For prophylaxis and/or treatment of vitamin D deficiency
Stay connected, subscribe to our newsletter for news and updates.